Optimal Drug Dosing to Prevent Chemotherapy Induced Neutropenia

Author:

Radisavljevic-Gajic Verica1,Karagiannis Dimitrios2

Affiliation:

1. Ajman University

2. Temple University

Abstract

Abstract In the first part of this paper, we have considered the well-known myelosuppression mathematical model of Lena Friberg and her coworkers from the system analysis point of view. We have studied the linearized model at steady state and considered its stability, controllability, observability, and scaling of model variables. It was noticed that the linearized dynamics of two state variables is slow (corresponding to the numbers of maturing cells in the third compartment and the number of circulating cells) and that three remaining state variables display fast dynamics (corresponding to the number of proliferative cells and the number of maturing cells in the first and second compartments). In order to avoid numerical computations with large numbers scaling of system state variables by a factor of \({10^9}\) has been utilized. An interesting and important result regarding a dosing strategy has been obtained by simulating dynamics of the considered nonlinear system and observing the steady state value for the number of circulating neutrophil cells. In the second part of the paper, a method was proposed for optimal chemotherapy dosing using a result from optimal control theory in order to reduce the amount of administrated chemotherapy drugs and to keep the number of neutrophil cells above a pre-specified desired ANC (actual neutrophil count) level. It was shown that in the case of continuous dosing, the variable optimal amounts of the drug have to be administrated daily based on information regarding the actual count of neutrophils. This result mathematically establishes that administrating constant amount of drugs daily cannot provide the optimal dosing schedule. In general, the obtained results open a door for modern personalized and optimized medicine that requires daily monitoring of fundamental variables and daily drug administration in variable quantities based on the actual state of the patient’s fundamental variables (parameters) for the considered decease.

Publisher

Research Square Platform LLC

Reference25 articles.

1. Model of chemotherapy-induced myelosuppression with parametric consistency across drugs;Friberg LE;J Clin Oncol,2002

2. Mechanistics models for myelosuppression;Friberg LE;Investig New Drugs,2003

3. Rosenbaum SE (2016) Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook and Computer Simulations. John Wiley & Sons, Hoboken

4. Towards quantitative systems pharmacology model of chemotherapy-induced neutropenia;Craig M;Pharmacometrics and Systems Pharmacology,2017

5. Jose Perez-Ruixo: Population pharmacokinetic-pharmacodynamics analysis of neutropenia in cancer patients receiving PM00104 (Zylypsis);Gonzales-Sales M;Clin Pharmacokinet,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3